Mexico and US child vaccine schedules, side by side

Document: PDF file date 16 Jul 2026 (document metadata, not a publication date; the cartilla prints "AÑO DE IMPRESIÓN: 2026" on PDF page 2).

The cartilla’s schedule table is "de conformidad con" the Manual de Vacunación 2021, the Lineamientos Generales del Programa de Vacunación Universal (PVU), the Enmienda al PVU de febrero 2026 and the Lineamientos de Temporada Invernal vigentes, and notes that the Esquema Nacional de Vacunación is subject to updates of national vaccination policy and other applicable provisions; the cover (PDF page 1) says the document is free ("gratuito") and PDF page 2 prints "AÑO DE IMPRESIÓN: 2026".

• At birth ("Al nacer") the table lists BCG (single dose; tuberculosis meníngea y miliar) and hepatitis B (single dose)
• Hexavalente (DPaT+VPI+Hib+HepB) is listed at 2 months (primera), 4 months (segunda), 6 months (tercera) and 18 months (refuerzo); DPT refuerzo at 4 years
• Rotavirus is listed at 2 months (primera) and 4 months (segunda)
• Conjugate pneumococcal vaccine is listed at 2 months (primera), 4 months (segunda) and 12 months (refuerzo)
• SRP (triple viral: sarampión, rubéola, parotiditis) is listed at 12 months (primera) and 18 months (segunda, regular schedule); a second dose at 6 years applies only to children born before July 2020, as a transitional strategy during 2026; in an outbreak or vaccine-blockade scenario children aged 6 to 11 months may receive a dose zero of SR or SRP, which does not replace the first regular dose at 12 months
• Hepatitis A is listed as a single dose at "18 meses o sin antecedente vacunal"
• Varicella is listed as a single dose at 12 months, with a note that it is not part of the universal basic schedule and is to be recorded when given in guarderías or child-care centres
• Influenza (types A and B): primary scheme of two doses from 6 months with a minimum interval of 4 weeks, then an annual dose each winter season until 59 months; for children aged 5 to 9 years with risk factors (asthma, immunosuppression, type 1 diabetes, heart disease, etc.) the table’s "Primera dosis" row shows "5 años" and "4 semanas después de la primera", and its "Segunda dosis / Dosis anual" row shows 6, 7, 8 and 9 años; footnote f says to give an annual dose at 5 to 9 years only to children with risk factors
• COVID-19: the same footnote e applies as for influenza (primary scheme of two doses from 6 months, minimum interval 4 weeks, then an annual dose each winter season until 59 months); from 5 to 9 years an annual dose only for children with risk factors (footnote f)

Source: gob.mx

Document: cdc.gov schedule page headed “Addendum updated July 2, 2025”; the rows quoted here are selected visits, from birth to the 4 to 6 years visit, and the page also carries older ages.

• At birth, the cdc.gov table marks as routine, risk-based or shared decision: Hepatitis B: 1st dose; RSV antibody: 1 dose depending on maternal RSV vaccination status, see the notes on the page. (The page's other bar types are not listed here.)
• At 1 month, the cdc.gov table marks as routine, risk-based or shared decision: Hepatitis B: 2nd dose; RSV antibody: 1 dose depending on maternal RSV vaccination status, see the notes on the page. (The page's other bar types are not listed here.)
• At 2 months, the cdc.gov table marks as routine, risk-based or shared decision: Hepatitis B: 2nd dose; RSV antibody: 1 dose depending on maternal RSV vaccination status, see the notes on the page; Rotavirus: 1st dose; DTaP (diphtheria, tetanus, whooping cough): 1st dose; Hib: 1st dose; Pneumococcal conjugate: 1st dose; Polio (IPV): 1st dose; Meningococcal ACWY: certain high-risk groups, see the notes on the page. (The page's other bar types are not listed here.)
• At 4 months, the cdc.gov table marks as routine, risk-based or shared decision: RSV antibody: 1 dose depending on maternal RSV vaccination status, see the notes on the page; Rotavirus: 2nd dose; DTaP (diphtheria, tetanus, whooping cough): 2nd dose; Hib: 2nd dose; Pneumococcal conjugate: 2nd dose; Polio (IPV): 2nd dose; Meningococcal ACWY: certain high-risk groups, see the notes on the page. (The page's other bar types are not listed here.)
• At 6 months, the cdc.gov table marks as routine, risk-based or shared decision: Hepatitis B: 3rd dose; RSV antibody: 1 dose depending on maternal RSV vaccination status, see the notes on the page (only part of the bar is this category; see the page); RSV antibody: certain high-risk groups (only part of the bar is this category; see the page); Rotavirus: see the notes on the page; DTaP (diphtheria, tetanus, whooping cough): 3rd dose; Hib: see the notes on the page; Pneumococcal conjugate: 3rd dose; Polio (IPV): 3rd dose; COVID-19: shared clinical decision-making, see the notes on the page; Flu (influenza): 1 or 2 doses annually; MMR (measles, mumps, rubella): certain high-risk groups, see the notes on the page; Hepatitis A: certain high-risk groups, see the notes on the page; Meningococcal ACWY: certain high-risk groups, see the notes on the page. (The page's other bar types are not listed here.)
• At 12 months, the cdc.gov table marks as routine, risk-based or shared decision: Hepatitis B: 3rd dose; RSV antibody: certain high-risk groups: 1 dose (8 through 19 months), see the notes on the page; Hib: 3rd or 4th dose, see the notes on the page; Pneumococcal conjugate: 4th dose; Polio (IPV): 3rd dose; COVID-19: shared clinical decision-making, see the notes on the page; Flu (influenza): 1 or 2 doses annually; MMR (measles, mumps, rubella): 1st dose; Chickenpox (varicella): 1st dose; Hepatitis A: 2-dose series, see the notes on the page; Meningococcal ACWY: certain high-risk groups, see the notes on the page. (The page's other bar types are not listed here.)
• At 15 months, the cdc.gov table marks as routine, risk-based or shared decision: Hepatitis B: 3rd dose; RSV antibody: certain high-risk groups: 1 dose (8 through 19 months), see the notes on the page; DTaP (diphtheria, tetanus, whooping cough): 4th dose; Hib: 3rd or 4th dose, see the notes on the page; Pneumococcal conjugate: 4th dose; Polio (IPV): 3rd dose; COVID-19: shared clinical decision-making, see the notes on the page; Flu (influenza): 1 or 2 doses annually; MMR (measles, mumps, rubella): 1st dose; Chickenpox (varicella): 1st dose; Hepatitis A: 2-dose series, see the notes on the page; Meningococcal ACWY: certain high-risk groups, see the notes on the page. (The page's other bar types are not listed here.)
• At 18 months, the cdc.gov table marks as routine, risk-based or shared decision: Hepatitis B: 3rd dose; RSV antibody: certain high-risk groups: 1 dose (8 through 19 months), see the notes on the page; DTaP (diphtheria, tetanus, whooping cough): 4th dose; Polio (IPV): 3rd dose; COVID-19: shared clinical decision-making, see the notes on the page; Flu (influenza): 1 or 2 doses annually; Hepatitis A: 2-dose series, see the notes on the page; Meningococcal ACWY: certain high-risk groups, see the notes on the page. (The page's other bar types are not listed here.)
• At 4 to 6 years, the cdc.gov table marks as routine, risk-based or shared decision: DTaP (diphtheria, tetanus, whooping cough): 5th dose; Hib: certain high-risk groups (only part of the bar is this category; see the page); Pneumococcal conjugate: certain high-risk groups (only part of the bar is this category; see the page); Polio (IPV): 4th dose; COVID-19: shared clinical decision-making, see the notes on the page; Flu (influenza): 1 or 2 doses annually; MMR (measles, mumps, rubella): 2nd dose; Chickenpox (varicella): 2nd dose; Meningococcal ACWY: certain high-risk groups, see the notes on the page. (The page's other bar types are not listed here.)

Source: cdc.gov